Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 51Lung Neoplasms 40Carcinoma, Non-Small-Cell Lung 28Neoplasm Metastasis 25Brain Neoplasms 23Lymphoma, Large B-Cell, Diffuse 22Pancreatic Neoplasms 21Glioma 20Breast Neoplasms 19Squamous Cell Carcinoma of Head and Neck 18Glioblastoma 17Multiple Myeloma 16Urinary Bladder Neoplasms 13Colorectal Neoplasms 13Carcinoma, Renal Cell 13Mouth Neoplasms 12Oropharyngeal Neoplasms 11Lymphoma, Mantle-Cell 11Carcinoma 11Triple Negative Breast Neoplasms 10Melanoma 10Leukemia, Lymphocytic, Chronic, B-Cell 10Laryngeal Neoplasms 10Ovarian Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Nasopharyngeal Carcinoma 8Lymphoma, Follicular 8Leukemia, Myeloid, Acute 8Hypopharyngeal Neoplasms 8Lymphoma, B-Cell 7

Interventions

Blood Specimen Collection 2posaconazole 1Surveys and Questionnaires 1Specimen Handling 1Phlebotomy 1Minoxidil 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Fluconazole 1Demography 1Cephalexin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Genetic Predisposition to Disease × Magnetic Resonance Spectroscopy × Clear all
NCT06636526 2026-02-04

The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).

Institute of Cancer Research, United Kingdom

Recruiting
1,000 enrolled
Genitourinary

Genetic Risk Score, Prostatic Neoplasms, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡